other_material
confidence high
sentiment positive
materiality 0.70
Telomir Pharmaceuticals announces positive preclinical data for Telomir-1 in progeria cell lines
Telomir Pharmaceuticals, Inc.
- Telomir-1 significantly increased cell viability in human HGPS cells under basal and metal-toxic conditions.
- Telomir-1 normalized reactive oxygen species (ROS) levels in Progeria cells, reducing oxidative stress.
- Telomir-1 reversed calcium overload, restoring mitochondrial function and energy balance.
- Company is finalizing IND-enabling studies and plans to engage FDA for orphan drug designation.
- Data builds on prior Telomir-1 results in Werner syndrome models (zebrafish, C. elegans) showing lifespan extension.
item 8.01